Clinical Immunogenicity of rHuPH20, a Hyaluronidase Enabling Subcutaneous Drug Administration.

Authors:
Rosengren S; Dychter SS; Printz MA; Huang L; Schiff RI and 8 more

Journal:
AAPS J

Publication Year: 2015

DOI:
10.1208/s12248-015-9782-0

PMCID:
PMC4540732

PMID:
25967925

Journal Information

Full Title: AAPS J

Abbreviation: AAPS J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Drug Therapy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"The authors wish to thank Drs. Robert Connor and Ge Wei for assistance with protein purifications, and Dr. Rose Sekulovich for assistance with extended characterization of purified antibodies. These studies were funded by Halozyme Therapeutics, Baxter Healthcare Corporation, and Roche."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025